Application of physiologically based kinetic (PBK) modelling in the next generation risk assessment of dermally applied consumer products.


Journal

Toxicology in vitro : an international journal published in association with BIBRA
ISSN: 1879-3177
Titre abrégé: Toxicol In Vitro
Pays: England
ID NLM: 8712158

Informations de publication

Date de publication:
Mar 2020
Historique:
received: 06 11 2019
revised: 04 12 2019
accepted: 09 12 2019
pubmed: 15 12 2019
medline: 29 9 2020
entrez: 15 12 2019
Statut: ppublish

Résumé

Next Generation Risk Assessment (NGRA) is a procedure that integrates new approach methodologies (NAMs) to assure safety of a product without generating data from animal testing. One of the major challenges in the application of NGRA to consumer products is how to extrapolate from the in vitro points of departure (PoDs) to the human exposure level associated with product use. To bridge the gap, physiologically based kinetic (PBK) modelling is routinely used to predict systemic exposure (C

Identifiants

pubmed: 31837441
pii: S0887-2333(19)30834-3
doi: 10.1016/j.tiv.2019.104746
pii:
doi:

Substances chimiques

Cosmetics 0
Coumarins 0
Detergents 0
Isothiocyanates 0
Sulfoxides 0
Caffeine 3G6A5W338E
coumarin A4VZ22K1WT
sulforaphane GA49J4310U

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

104746

Informations de copyright

Copyright © 2019 The Authors. Published by Elsevier Ltd.. All rights reserved.

Auteurs

Thomas E Moxon (TE)

Unilever Safety and Environmental Assurance Centre, Colworth Science Park, Sharnbrook, Bedfordshire MK44 1LQ, UK. Electronic address: tom.moxon@unilever.com.

Hequn Li (H)

Unilever Safety and Environmental Assurance Centre, Colworth Science Park, Sharnbrook, Bedfordshire MK44 1LQ, UK.

Mi-Young Lee (MY)

Unilever Safety and Environmental Assurance Centre, Colworth Science Park, Sharnbrook, Bedfordshire MK44 1LQ, UK.

Przemyslaw Piechota (P)

Unilever Safety and Environmental Assurance Centre, Colworth Science Park, Sharnbrook, Bedfordshire MK44 1LQ, UK.

Beate Nicol (B)

Unilever Safety and Environmental Assurance Centre, Colworth Science Park, Sharnbrook, Bedfordshire MK44 1LQ, UK.

Juliette Pickles (J)

Unilever Safety and Environmental Assurance Centre, Colworth Science Park, Sharnbrook, Bedfordshire MK44 1LQ, UK.

Ruth Pendlington (R)

Unilever Safety and Environmental Assurance Centre, Colworth Science Park, Sharnbrook, Bedfordshire MK44 1LQ, UK.

Ian Sorrell (I)

Unilever Safety and Environmental Assurance Centre, Colworth Science Park, Sharnbrook, Bedfordshire MK44 1LQ, UK.

Maria Teresa Baltazar (MT)

Unilever Safety and Environmental Assurance Centre, Colworth Science Park, Sharnbrook, Bedfordshire MK44 1LQ, UK.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH